发明名称 TREATMENT OF MULTIPLE SCLEROSIS WITH COMBINATION OF LAQUINIMOD AND FLUPIRTINE.
摘要 This invention provides a method of treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome comprising administering to the subject laquinimod as an add-on therapy to or in combination with flupirtine. This invention also provides a package and a pharmaceutical composition comprising laquinimod and flupirtine for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention also provides laquinimod for use as an add-on therapy or in combination with flupirtine in treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome. This invention further provides use of laquinimod and flupirtine in the preparation of a combination for treating a subject afflicted with multiple sclerosis or presenting a clinically isolated syndrome.
申请公布号 MX2016001177(A) 申请公布日期 2016.04.29
申请号 MX20160001177 申请日期 2014.07.30
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 DAVID SILVER;EINAT AMIT ROMACH
分类号 A61K31/4704;A61K31/44 主分类号 A61K31/4704
代理机构 代理人
主权项
地址